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ABSTRACT
By means ofEPR spectroscopy the behaviour of the vanadocene dichloride (I), CIVC12 (Cp rl-
CH), in various deoxygenated and non-deoxygenated physiological media and therapeutic solution as well
as in blood plasma and stabilized human blood was studied. On the basis of measured values of isotropic
spectroscopic splitting factor gi, and isotropic hyperfine coupling constant Aso, the vanadocene species,
[CIV(H20)C1]
+ (II; giso 1.985, I,ol 7.68 mW), [Cp2V(H20)2]
2+ (III; gi, 1.983, I&ol 7.92 mT),
CIV(OH)2 (IV; gio 1.991, I,ol 6.285 mT), [CIVCI(DMSO)]
+ (V; go 1.985, Iol 7.69 mT), the
vanadyl species [VO(DMSO)]
2+ (VI; go 1.964, Iol- 10.78roT) and [VO(H20)]+ (VII; g{o 1.955,
IAol 11.56 mT) have been identified. From the measurements it follows that I does not react in its first
coordination sphere with any component of a system used other than water and DMSO, resp. As to water-
containing media, its behaviour is fully consistent with that of I in pure aqueous media. It was found the
only vanadocene species present after application of the therapeutic solution of I into human blood to be IV
not interacting in its first coordination sphere with any blood component.
INTRODUCTION
Vanadocene dichloride (I), CpaVC12 (Cp q-CsHs), belongs to the class of metallocene dihalides,
CIMX (M Ti, V, Nb, Mo; X halide), representing a novel family of potent antitumor organometallic
agents [1,2]. Its antitumor activity has been discovered by K6pf-Maier and K6pf [3]. Vanadocene dichloride
was shown to be characterized by marked antiproliferative effects against some cultured animal and human
tumor cells (murine Ehrlich ascites tumor [4], human KB as well as HeLa tumor [1], HEp-2 human
epidermoid carcinoma [5-7] or normal, not transformed cells (human embryonic fibroblasts [8] ) in vitro
as well as by systemic antineoplastic activity against several experimental tumor systems (fluid and solid
Ehrlich ascites tumor [3,8] or TA3Ha murine mammary adenocarcinoma [5-7] in vivo. Various biological
experiments (such as electron energy loss-spectroscopy microanalysis showing the main accumulation of
vanadium in nuclear heterochromatin [9,10], precursor incorporation studies revealing inhibition of nucleic
acid synthesis activities 11], cytokinetic investigations revealing mitotic depressions in tumor cells treated
with I in vitro [12] and in vivo [13], cytological and morphological analysis of histological and
ultrastructural alterations of animal Ehrlich ascites tumor cells treated with I in vivo [14] and human
embryonic fibroblasts treated with I in vitro [8] ) pointed to the nucleic acids, especially DNA, as probable
primary intracellular target for I.
There is number of problems arising from the use of metallocene dichlorides as cytostatics. These
are related to the knowledge of the nature of a genuine active metallocene species present in physiological
and therapeutic media, to the understanding of the molecular mode of antitumor action of antitumor
inhibiting metallocene dihalides. Thus, the tasks to be solved may be formulated as follows: (i) the
elucidation of the nature of species arising from CIMX2 in aqueous, therapeutic and physiological media,
(ii) the study of the interaction metallocene species biomolecule (a) in the course of the transport into the
tumor cell, (b) inside the tumor cell (molecular mechanism of the oncostatic action).
207Vol 4, No. 4, 1997 Behaviour ofthe Antitumour Agent Vanadocene Dichloride in Physiological
and Therapeutic Media, Blood Plasma and Human Blood- An EPR Study
The metallocene complex I appears to be especially attractive for solving problems above. The
paramagnetism of the central metal atom d V(IV) and its nuclear spin (IV: 1=7/2, abundance 99.8%) make
I to be a suitable EPR structural probe.
The following problems are formulated for this study: (i) to elucidate the nature of species arising from I
in physiological and therapeutic media, (ii) to investigate the interaction of I with blood plasma and
stabilized human blood. Therefore, the detailed knowledge of the aqueous chemistry of I seems to be a
prerequisite to get an insight into the nature of interactions of I with components of physiological and
therapeutic solutions as well as of interactions l-biomolecule both in extracellular medium and in tumor
cells.
Recently, Toney and Marks [15] have described the hydrolysis kinetics and equilibria for I and
proposed a scheme for its hydrolysis consisting of a sequence of aquation and dissociation equilibria
(Scheme I). It was found that the V-Cp bonds exhibited the long-lasting hydrolytic stability at physiological
pH thus preserving the structural integrity of the vanadocene unit [Cp2V]+.
On the basis of combined results of the chloride potentiometry and pH titrimetry, Toney and Marks
[15] anticipated not only quantitative loss ofboth chloride ligands of the molecule I in the blood plasma, but
also the existence of aqua and hydroxo vanadocene complexes as prevailing forms of hydrolysis products.
They also supposed the vanadocene dihydroxide IV to be a prevailing vanadocene species in the blood
plasma.
SCHEME Hydrolysis of Cp2VC12 [15]
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In a previous study [16] various hydrolysis species formed from I in strongly acidic, neutral and
alkaline aqueous solutions were identified and characterized by the values of the isotropic spectroscopic
splitting factor giso and isotropic hyperfine coupling constant IA,ol measured by means of EPR
spectroscopy. In strongly acidic aqueous solutions the only vanadocene species [Cp2V(H20)2]
2+ (III; giso
1.9828, IA.I 7.92 mT) is present (stable for several days). In strongly acidic 0.103M NaC1 solution the
prevailing species III coexists in equilibrium with [CV(H20)C1]
+ (II; gio= 1.9848, ]Ao] 7.68 roT). The
latter species II was unambiguously identified in concentrated HC1 solutions, where it coexists in equilibria
with either I or III depending on the HC1 concentration. Vanadocene dihydroxide, Cp2V(OH)z (IV; go
1.9907, IA,ol 6.285 mT), was the only vanadocene complex identified at physiological and higher pH
values. Its EPR signal has completely disappeared after 72h-exposure of the solution to air.
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MATERIALS AND METHODS
Compounds and solutions
Vanadocene dichloride (I) was prepared by the published method [17] and purified by anaerobic
Soxhlet extraction with chloroform. The purity of I was checked by elemental analysis as well as by IR,
EPR and UV/VIS spectroscopies. The purified compound was handled under oxygen-free Ar using standard
Schlenk techniques and was stored under Ar in sealed vials. Me2SO (Fluka) was thoroughly dried.
As solvents the standard physiological solutions [Ringer" 6.50 g (0.111 mol) NaC1, 0.1.4 g (1.88
mmol) KC1, 0.12 g (1.08 mmol) CaC12, 0.20 g (2.38 mmol) NaHCO3 1000ml solution; Ringer-Lock 9.00
g (0.154 tool) NaC1, 0.42 g (5.63 mmol) KC1, 0.24 g (2.16 retool) CaCl, 0.20 g (2.38 mmol) NaHCO3,
1.00 g (5.55 retool) D-glucose 1000ml solution; Ringer-Tyrod 8.00 g (0.137 tool) NaC1, 0.20 g (2.68
mmol) KC1, 0.20 g (1.80 retool) CaCl, 0.10 g (1.19 mmol) NaHCO3, 0.10 g (1.05 retool) MgC12, 0.05 g
(0.417 mmol) NaH2PO4, 1.00 g (5.55 mmol) D-glucose 1000ml solution; Krebs-Ringer 6.895 g (0.118
mol) NaC1, 3.355 g (0.048 mol) KC1, 0.277 g (2.50 mmol) CaC12, 0.163 g (1.18 retool) KH2PO4, 0.144 g
(1.20 mmol) MgSO4, 2.100 g (0.025 tool) NaHCO3 1000ml solution; saline 6.02 g (0.103 mol) NaC1
1000ml solution; D-glucose" 41.46 g (0.230 tool) 1000ml solution], Me,SO and the therapeutic solvent
system [saline (0.103M NaC1) and Me,SO (9:1 v/v)] were employed. All chemicals were analytical grade.
Deionized double-distilled water was used throughout these experiments.
The blood plasma stabilized with sodium hydrogen citrate was purchased from hnuna (arisk6
Michalany, Slovac Republic) and used as received. The whole human blood used for this study was taken
from a healthy man (age of 26 years) and stabilized using EDTA.
Measurements
EPR spectra were recorded on a X-band spectrometer ESR 221 (ZWG Berlin, Germany) at room
temperature in time intervals ranging from 150 s up to several hours or even days after introducing I into
solvent system. The experimental giso and &so values determined from recorded EPR spectra by the standard
procedure were corrected for the second- order effects [18]. In order to estimate the abundance ratio (in %)
of various vanadium(IV) containing species in a studied solution or solvent system the recorded EPR
spectral first derivate curves consisting of two or more superposed eight-line signals were computer-
deconvulated into separate ones corresponding to the respective species. Their abudance ratio was then
estimated from the ratio of integral signal areas obtained by double integrating the individual deconvoluted
first derivative signals.
The pH measurements were performed with a pH meter MV-870 Digital pH-Messgerit using a
glass electrode Radelkis OP-0808P. The pH meter was calibrated with buffers Radelkis ,,K-21" pH (25C)
2.15 and ,,K-91" pH (25C) 9.21.
For preparing and handling solutions of I the special all-glass cell developed in our laboratory was
employed which made possible all operations preceding the EPR measurement (such as introduction and
dissolution of I, adjustment and control ofpH concentration, saturation and purging with Ar, sampling and
filling EPR capillary tubes) to be made under argon atmosphere. If necessary, the pH adjustments were
made with either concentrated NaOH or HC104.
209Vol 4, No. 4. 1997 Behaviour ofthe Antitumour Agent Vanadocene Dichloride in Physiological
and Therapeutic Media, Blood Plasma and Human Blood- An EPR Study
RESULTS
In order to identify species arising from I in physiological and therapeutic media as well as in
blood plasma and human blood it has been taken advantage of the fact analogously to our previous study
[16] that the complexes of CpVX2, [Cp2VLX]+, and [CpVLa]2+, where X represents a monoanionic
ligand, and L an uncharged unidentate ligand, generate an eight-line EPR spectrum due to the hyperfine
coupling of unpaired d electron with the 51V (I 7/2; 99.8%) nucleus. These eight-line spectra can be
explained using the spin Hamiltonian H 13gisoHS + AisdrS for systems with S 1/2 and applying second
order correction.
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Fig. 1. EPR spectra of vanadocene dichloride in various solutions and solvents (150s after substance
introduction into solution; concentration in I" 10
-3M ).
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EPR spectra of I in physiological solutions and in the therapeutic solution DMSO/saline
EPR spectra were measured in both deoxygenated solutions (solvents used were bubbled with pure
argon for 30 min at 60C and the samples for measuring were prepared under argon atmosphere) and in
non-deoxygenated solutions (solvents used were not deoxygenated and the samples were prepared under
atmospheric air using standard techniques). The solutions for biological and pharmacological experiments
were probably used in the latter manner. In the following the deoxygenated solutions treated in the
corresponding way will be always meant unless stated otherwise.
Ringer solution
I dissolved in the Ringer physiological solution affords 150s after substance introduction into
solution a complex EPR spectrum (Fig.la) consisting of three eight-line superposed signals belonging to
three different vanadooene species. The most intense eight-line signal is characterized by EPR parameters
I,ol 7.92 mT and giso 1.981, both corresponding to the species III (see [16]). The second, less intense
eight-line signal with EPR parameters [Ao[ 6.30 mT and go 1.991 corresponds to the vanadocene
dihydroxide IV. On the last two high-field lines of the signal the presence of an additional weak line could
be resolved. The EPR parameters of this third partially resolved eight-line signal, I,ol 7.63 mT and giso
1.985, can be assigned to the species II as shown previously [16]. 24h after introduction of I into the
Ringer solution the traces of the fourth eight-line signal (1,ol 11.60 mT, gi, 1.958) appeared. This
signal is unambiguously characteristic ofvanadyl species VII. The intensity of this signal gets stronger with
increasing time.
Ringer-Lock solution
I dissolved in the Ringer-Look physiological solution displays 150s after substance introduction
into solution a complex EPR spectrum consisting analogously to the preceding case of three eight-line
superposed signals belonging to the three species present (Fig.lb): III ([A,o] 7.92 mT, g,o 1.983), IV
(1,ol 6.30 mT, g,o 1.991) and II (1,ol 7.63 mT, g,o 1.985). The latter species can be identified
through an additional weak line, which is discernible on the last two high-field lines of the spectrum. Also
in this case the traces of the fourth eight-line signal (]Ao[ 11.60 mT, g,o= 1.958) appeared 24h after
introduction of I into the Ringer-Look solution. This additional signal whose intensity increases with time
can be again assigned to the species VII.
Ringer-Tyrod solution
I dissolved in the Ringer-Tyrod solution displays similarly a complex EPR spectrum consisting of
three eight-line superposed signals, only differing in the relative abundance of three vanadocene species
(Fig.lc). The most abundant species shows to be III ([Ai,o[ 7.92 mT, giso 1.983), while the species IV is
present in much lesser amount ([Ai,o[ 6.30 mT, gi,o-- 1.991). A slight amount of the species II ([Ao[
7.63 mT, gi, 1.985) is also present. Similarly to the preceding cases the traces of the vanadyl species VII
appeared in the EPR spectrum 24h after introduction of I into solution (]Ao[ 11.60 mT, go= 1.958). The
signal intensity of the latter species increased with time.
Krebs-Ringer solution
I dissolved in this physiological solution shows also 150s after introduction of I into solution
the simple eight-line EPR spectrum with magnetic parameters ([A,o[ 6.29 mT, go 1.991)
corresponding to the species IV (Fig.ld). The measured spetrum remains unchanged in its shape,
parameters and intensity for at least 24h.
Physiological saline
I in physiological saline (103 mM NaC1) similarly affords a marked eight-line EPR spectrum
corresponding to the diaquavanadooene dication III ([Aio[ 7.92 mT, go= 1.983) (Fig. le). The additional
line (]A,o[ 7.63 mT, gso= 1.985) superposed on each of the two high-field lines of the eight-line signal
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gives evidence for the simultaneous presence of a tiny amount of a species II. 24h after substance
introduction into saline the traces of the third eight-line signal corresponding to the species VII (IAol
11.60 mT, giso 1.958) appeared and increased.
D-glucose
I in isotonic aqueous D-glucose solution shows the eight-line EPR spectrum corresponding to the
species III (lol 7.92 mT, giso 1.983) (Fig.If). 24h after introduction of I into solution the traces of
another eight-line signal of the species VII ([Ao[ 11.60 roT, gio 1.958) appeared. This signal increased
in intensity with time.
In order to elucidate the presence of species arising from I in all the physiological solutions
mentioned above the pH values of solutions before and after introduction of I were measured. The pH values
are given in Table I.
TABLE I. The pH values ofvarious physiolog;ical solutions without and with
Physiological solution without I with
Ringer
Ringer-Lock
Ringer-Tyrod
Krebs-Ringer
0.103 M NaC1
D-glucose
8.1
7.8
6.4
8.9
6.3
6.4
3.4
3.4
3.3
7.1
3.4
3.2
Solution used for EPR measurement
In addition to the EPR spectra measured in deoxygenated physiological solutions the measurements
given above have also been carried out in the presence of air oxygen. I dissolved in physiological solutions
(Ringer, Ringer-Lock, Ringer-Tyrod, Krebs-Ringer, saline and D-glucose) used without prior
deoxygenation exhibits the EPR spectra with magnetic parameters corresponding to the species II, III, VI
and VII.
DMSO/saline (v/v=l/9) therapeutic solution
The EPR spectrum of I was further investigated in the therapeutic solution (DMSO-saline v/v=l/9)
serving for metallocene cytostatic application in preclinical studies. These EPR measurements were carried
out 150s, lh, 24h, 48h and 6d after introduction of I into the therapeutic solution in order to ascertain what
kinds of vanadocene(IV) or vanadium(IV) species arise, persist and/or disappear. The EPR spectrum
recorded 150s after introduction of I into the therapeutic solution consists (Fig.lg) of three eight-line
signals corresponding to three different species. The prevailing species II! is characterized by an eight-line
signal having magnetic parameters I,ol 7.96 mT and gio 1.983. The second eight-line signal can be
assigned to a little amount of IV (1,ol 6.31 mT, gio 1.991). The third species, i.e. II, becomes evident
through weak lines superposed on the last two high-field lines (1,ol 7.63 mT, giso 1.984). The EPR
spectrum measured after lh is identical with the preceding one. After 24h the EPR spectrum shows the
presence of the fourth eight-line signal (l,ol 11.60 mT, gi, 1.958) of the additional species VII. The
spectrum of the same solution sample after 48h reveals that the present species are still the same but the
signal intensity of III decreases in favour of other three species. The spectrum recorded after 6d shows that
the signal intensities of four species present in solution are in the following order: III>VII>IV>II. The
magnetic parameters IA,,ol and go of respective vanadocene species are time independent.
150s after dissolving I in the non-deoxygenated therapeutic solvent, the EPR spectrum exhibits
four simple eight-line signals corresponding to four various vanadium species. The prevailing species is III
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(IAol 7.96 mT, giso 1.983). The other species VII (IA,ol 11.60 mT, giso 1.958), IV (lAsso] 6.31
mT, giso 1.991) and II (IA,ol 7.63 mT, gio 1.984) are present in minor amounts, the latter being only
discernible through weak lines superposed on the last two intense high-field lines. This system was also
investigated at five different time intervals (150s, lh, 24h, 48h, 6d) after sample preparation. The spectrum
recorded after h consists of three eight-line signals. On the basis of their magnetic parameters these three
signals are assigned to the following species: IV with unchanged signal intensity, VII with increased signal
intensity and III having the most intense signal. With increasing time the signal intensity of VII increases
to the detriment of III. The signal intensity of IV remains unchanged. 48h after mixing I with the
therapeutic solvent the signal intensities of the species VII and III become equalized. IV is only present in a
minimum amount. The I,ol and gi,o parameters are time independent. 6 d after introduction of I into the
non-deoxygenated therapeutic solvent the only vanadium(IV) species present in examined solution is VII as
evidenced by the single eight-line signal exhibiting characteristic magnetic parameters [Aio[ 11.60 mT
and gi, 1.958.
DMSO
The EPR spectrum of I was also measured in neat DMSO which serves as a minor, auxiliary
component of the therapeutic solvent system used for preclinical animal tests as mentioned above. The time
dependence of the formation of various vanadocene and vanadium species was again monitored in
thoroughly deoxygenated DMSO. 150s after introduction of I into DMSO the simple eight-line EPR
spectrum was found (Fig. lh). The observed magnetic parameters (IAol 7.43 mT, gio 1.988) correspond
to those of I itself (for comparison: I in CHC13 exhibits IAol 7.43 mT, giso 1.9882 [17]). The EPR
spectrum of the same sample after 5min seems at first sight to be a simple eight-line signal having the same
magnetic parameters as that recorded after 150s. However, a careful examination of the spectrum allows to
detect additional lines superposed on the last two high-field lines and belonging apparently to the additional
eight-line signal of low intensity. The intensity of this signal having IAio] 7.68 mT and gi, 1.98
increases with time. The IA,ol and gio values of this new signal are conspicuously different from those of I
as well as from those of other vanadocene species hitherto described. We assign this newly appeared EPR
signal tentatively to the complex cation [CIVCI(DMSO)]
+ (its IAol and go values are very close to those
of II). 24h after introduction of I into DMSO an EPR spectrum is obtained consisting of two overlapping
eight-line signals. The present species are still the same except for the signal of I decreasing in intensity in
favour of [Cp2VCI(DMSO)]+. The spectrum of I in DMSO, measured after 3d, is identical with the
preceding (24h) one.
The above time dependence was also investigated in the presence of air oxygen. The obtained
isotropic EPR spectra consist oftwo eight-line signals corresponding to two different species. Undoubtedly,
the first species was I (IA,ol 7.44 mT, g,o 1.988). Another species (IAo[ 11.78 mT, gio 1.964)
appeared immediately after introducing I into DMSO and its signal increased with increasing time. The
EPR spectrum recorded after 24h was a simple eight-line signal corresponding only to one species. Its
magnetic parameters are different from those of I as well as of all other species hitherto identified. The
higher IA,ol value indicates the presence of a vanadyl species. We assign this eight-line EPR signal
tentatively to the cation [VO(DMSO)n]+ (for comparison, we have measured the EPR spectrum of VOSO4
in DMSO: its eight-line signal exhibits IA,ol 11.05 mT and g,o 1.969).
EPR spectra of I in blood plasma and whole blood
Biological experiments (see above) pointed to the nucleic acids, especially DNA of cellular nucleus,
as probable primary molecular target for antitumor active metallocene dihalides including I. Before the
metallocene molecule reaches the tumor cell, it has to pass the blood bed after its application in therapeutic
solution. In order to determine which vanadocene species does (or do) exist after introducing I
(DMSO/0.103M NaC1) into the blood bed we will now try to clarify the nature of interaction I blood
plasma and I- whole human blood.
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The blood plasma and the therapeutic solution were in no way treated (for example deoxygenated).
The preparation of samples for EPR measurements was carried out using standard techniques without inert
atmosphere.
2) simulation
b)
1) experiment
frq
H3X3[10"
Fig. 2. The EPR spectrum of the system I blood plasma at a) pH 3.71, b) pH 7.13 concentration in I:
104M ).
Bloodplasma I
The series of solutions I blood plasma were investigated in the pH range 0.12 9.13. The region
of physiological pH values was examined most thoroughly. The studied solutions give (250s after
introduction of I into solution and adjustment of pH value using 1M HC104 or 1M NaOH) complex EPR
spectra consisting of several simple eight-line signals ofvanadocene species.
I in blood plasma solutions having final pH values 0.12 3.35 shows a composite EPR spectrum
consisting of two eight-line signals (Fig.2a). The signal of markedly higher intensity with magnetic
parameters Iol 7.92 mT, giso 1.983 can be unambiguously assigned to the cation III. The other eight-
line signal whose intensity increases with increasing pH is characterized by magnetic parameters I,%ol
6.87 mT, go 1.984, which differ from those of all the vanadocene species studied till now. We assign this
new signal to a complex "vanadocene-citrate". This complex species arises probably through reaction of I
(or of another vanadocene species) with sodium hydrogen citrate used to stabilize the blood plasma. For
comparison we measured EPR spectrum of I in aqueous sodium hydrogen citrate. This solution (pH=4.2)
displays 250s after introduction of I an EPR spectrum consisting of two eight-line signals corresponding to
two species. The less intensive signal having I,%ol 7.92 mT, giso 1.983 corresponds to the cation III, the
other more intensive signal has magnetic parameters (1,ol- 6.87 mT, go 1.984) identical with those of
the species found in the system I blood plasma and designated as "vanadocene-citrate".
The systems I blood plasma with final pH values in the range from 3.35 to 7.13 exhibit complex
EPR spectra consisting of three eight-line signals. The first signal with intensity decreasing with increasing
pH and magnetic parameters [Ao[ 7.92 mT, gio 1.983 can be assigned to the cation III. The second
eight-line signal, whose intensity slightly decreases at limiting pH values of the given interval, corresponds
to the "vanadocene-citrate" species (1,ol 6.87 mT, gi,o 1.984). The third eight-line signal with intensity
increasing with increasing pH has magnetic parameters I,ol 6.29 mT, gso 1.991, corresponding
therefore to IV.
The EPR spectra of the system I- blood plasma with pH values in the range from 7.13 to 9.13
exhibit two superposed eight-line signals (Fig.2b). The first signal with intensity decreasing rapidly with
increasing pH belongs to the "vanadocene-citrate" species (I,%ol 6.87 mT, g,o 1.984), the other signal
(]A,o[ 6.29 mT, gi, 1.991), the intensity of which raises with increasing pH, can be unequivocally
assigned to the IV.
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Bloodplasma- I/therapeutic solution
I dissolved in the therapeutic solution (DMSO + 103 mM NaC1, 1:9 v/v) and added to the blood
plasma affords a solution of final pH= 6.32, which 150s after mixing exhibits an EPR spectrum consisting
of two simple eight-line signals. The more intense signal having Iol 6.87 mT, giso 1.984 corresponds
to the "vanadocene-citrate" species, the less intense one to the species IV (I.%ol 6.29 mT, giso 1.992).
Whole blood I
150s after introduction of I into human blood stabilized using disodium EDTA one obtains the
simple eight-line EPR spectrum corresponding to the single species IV.
Whole blood- I/therapeutic solution
I dissolved in the therapeutic solution and added to the whole blood stabilized using disodium
EDTA exhibits (after 250s) the simple eight-line EPR spectrum whose magnetic parameters I,ol 6.285
mT, go 1.991 corresponds unequivocally to the species IV.
DISCUSSION
The prerequisite for elucidating the nature of interactions I biomolecule in extracellular medium
is the detailed knowledge of the behaviour of I in various physiological solutions as well as in the
therapeutic solution used for in vivo applications. Considering that the physiological solutions are
essentially the aqueous ones, it is possible to take advantage of the scheme I for the behaviour of I in water
in order to discuss the vanadocene species present 15,16].
On the basis of application modes of I in physiological or therapeutic solutions mentioned in the
literature it may be presumed that the applied solutions were not deoxygenated. Therefore it was necessary
to investigate the behaviour of I both in deoxygenated and non-deoxygenated solutions.
As it follows from our studies of I in physiological solutions, the existence of species II, llI, IV,
and VII have been proven. These species exhibit the magnetic parameters identical with those of the species
recorded in aqueous solutions of I at various pH values and at various chloride ion concentrations 16]: II
(high CI concentration), III (pH 0-7), IV (pH 3.1-11.9), and VII. All of the species exhibit eight-line
EPR signals characteristic of the hyperfine d-electron 51V nucleus coupling. The magnetic parameters of
vanadocene(IV) or vanadium(IV) species identified by EPR are summarized in Table II.
TABLE II. The magnetic parameters ofvanadocene or vanadium species
Cp2VClK!)
[Cp2V(H_O)Cl]
+ (I1)
[Cp2V(H20)2]2+(III)
CpV(OHh(w)
[Cp2VCI(DMSO)]+ (V)
[VO(DMSO)5]2+(VI)
[VO(H20),12+(VII)
vanadocene-citrate
I&ol [mT]
7.43
7.68
7.92
6.285
7.69
10.78
11.56
6.87
giso
1.988
1.985
1.983
1.991
1.985
1.964
1.955
1.984
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The composite EPR spectra consisting of several superposed eight-line signals were resolved into separate
eight-line components. The abundance ratio of individual vanadocene and vanadium(IV) species formed by
dissolving I in a given solution was estimated as described in Materials and Methods. The resulting data
are summarized in Table III.
TABLE III. The abundance ratio of individual vanadocene and vanadyl species formed by dissolving I in a
physiological solution
I + phys. solution
t =150s" (24h)"
Ringer
Ringer-Lock
Ringer-Tyrod
Krebs-Ringer
Physiological saline
D-glucose
1 I%1
o(o)
o(o)
o(o)
0(0)
o(o)
o(o)
II [%1
11(8)
7(4)
18(14)
o(o)
17(16)
o(o)
In [%1
79 72 )
49 ( 47 )
75 ( 74
o(o)
83 82
100 96
IV [%1
10(12)
44( 45 )
7(7)
100 100
o(o)
o(o)
VII I%1
0(8)
0(4)
0(4)
o(o)
0(2)
0(4)
time of measurement after introduction of I
In the deoxygenated Ringer solution (Fig. la) being used for studies with cold-blooded animals the
species III, IV, and II (only traces) with magnetic parameters given in Table II were identified. In the
deoxygenated Ringer-Lock and Ringer-Tyrod solutions the same species were present although in slightly
differing relative amounts. These experimental findings can be explained on the basis of the virtually
identical pH values attained after dissolving I. The species IV alone is present in the deoxygenated Krebs-
Ringer solution (Fig. ld) which agrees with the previous measurement [16] showing the presence of the only
species IV in solutions of pH values 7.1 11.88. This is the only physiological solution studied which
attains a higher pH value, i.e. pH 7.1, after dissolving I. The deoxygenated saline I solution contains
the prevailing species III in addition to a small amount of II. The last of all examined deoxygenated
solutions, the isotonic solution D-glucose-I exhibits the presence of a single species, III (Fig. If ). All of the
deoxygenated physiological solutions of I afford EPR spectra which are constant in form, magnetic
parameters and intensities for at least 24 hours. With the exception of the Krebs-Ringer solution all of the
other solutions of I reveal a trace amount of VII after 24 h.
I dissolved in non-deoxygenated physiological solutions affords EPR spectra after 150s exhibiting
the presence of the species II, III, IV, and VII. In cc,trast to the EPR spectra of I in deoxygenated solutions
(150s after introducing I into solution), the eight-line signal characteristic of the pentaaquavanadyl cation
VII is observed in this case. The abundance ratios of all species correspond- with minute deviations to
those of these species formed in the corresponding deoxygenated physiological solution 24h after mixing
(Table III).
Next the I therapeutic solution system was investigated. This therapeutic solution used for
preclinical testing consists of DMSO and saline (1:9 v/v). DMSO acts as auxiliary solvent increasing the
solubility of I. In view of the fact that the therapeutic solution consists of two different components, it is
necessary to investigate the interaction of I with either components separately. Since the hydrolysis
behaviour of I in saline is already known, it was also necessary to investigate the interaction of I in the
other, though minor component of the therapeutic solution, i.e. DMSO.
By means of EPR, only two species have been found in the deoxygenated water-free DMSO mixed
with I. I affords simple eight-line EPR signal of the intact I measured 150s after mixing I with DMSO.
Already after 5 min yet one additional eight-line signal appears in addition to the signal of I. The intensity
of this additional signal increases with time and its magnetic parameters differ significantly from those of
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all other vanadocene species hitherto identified. On the basis of the arguments given below this signal has
been assigned to the [Cp2VCI(DMSO)]
+ species (V). The EPR spectrum of I in non-deoxygenated DMSO
consists of two signals, one corresponding to I and the other probably to the [VO(DMSO)n]
2+ species. This
new signal appeared immediately after mixing I with DMSO (150s) and its intensity raised with time. After
24h the [VO(DMSO)n]
2+ species was the only one present.
From EPR measurements in the deoxygenated and non-deoxygenated DMSO we can draw the
following conclusions: (i) In the absence of air oxygen the substitution of one CI ligand for the DMSO
molecule occurs in the course of time
CpaVC12 + DMSO [CI:hVCI(DMSO)]
+ + C1.
The coordination of one DMSO molecule resembles that of one H20 molecule during dissolving I in a water
solution of a high CI concentration:
CIVCla + H_O -’-’ [CpV(H:O)C]+ + Cf.
The close similarity can be observed between the two vanadocene monochloride cationic species, which is
due to the fact that one O-donor is always coordinated to the vanadium center through the O-atom in both
species. (ii) In the presence of air oxygen the two Cp ligands of I are displaced to give perhaps a vanadyl-
DMSO complex, having probably the [VO(DMSO)]+ (VI) formula corresponding to the analogous aqua
complex [VO(HO)5]
2/ (VII). In view of the fact that these two vanadyl species contain six oxygen donor
atoms in the first coordination sphere of the V center, the similarity of their giso and Aso values (Table II) is
not surprising. The identity of the [VO(DMSO)]+ (VI) species is supported by the ESR spectrum of the
vanadyl sulphate-DMSO solution which displays one eight-line signal with magnetic parameters identical
with those of the [VO(DMSO)5]
:+ species presumed to be present in the I-DMSO under exposure to air.
Three species, i.e. II, Ill, and IV, have been observed in the deoxygenated therapeutic solution
saline/DMSO (Fig. lg) 150s after introduction of I. Neither [VO(DMSO)]+ (VI) nor [CIVCI(DMSO)]" (V)
have been observed. 24h after introducing I into solution the signal of the [VO(HaO)5]
2/ species appeared in
the EPR spectrum. Its intensity raises with increasing time whereas the intensities of other signals decrease.
I in the therapeutic solution under conditions used for both in vivo and in vitro biological experiments
exhibits EPR spectra consisting of eight-line signals corresponding to the species II, III, IV, and VI. These
four species are already present 150s after introducing I into the therapeutic solvent system. The signal
corresponding to the cation II disappeared within h. Also the intensity of the complex IV diminishes so
that it is only present in trace amounts after 48h. On the other hand, the intensity of the signal
corresponding to the cation VII raises with increasing time while that of the cation III simultaneously
drops. Apparently the analogous mechanism applies here as for the reaction I non-deoxygenated water
(pH 0-3.0). The sole species VII is observable 6 days after introducing I into non-deoxygenated
therapeutic solvent system. The species V and VI found both in non-deoxygenated and deoxygenated
DMSO were not observed in the non-deoxygenated therapeutic solvent system. The dominant component
(i.e. H20 + NaC1) of the used therapeutic solvent system is the only component which is coordinatively
effective in the interaction with I in an experimentally interceptible manner in contrast to the minor
component (DMSO).
Now we will try to answer the following question: what specific vanadocene(IV) or vanadium(IV)
species will be present in the blood plasma and the whole blood after application of antitumor active I ?
Since both the blood plasma and the blood represent essentially the aqueous systems, it is possible to use the
known hydrolysis scheme of I for discussion of the relevant species. In order to ascertain the nature of
resulting species we may get out of the behaviour of I in physiological solutions. The composition of the
used physiological solutions namely mimics the mineral composition of the blood and the plasma, as well.
All of the measured EPR spectra were resolved into separate simple eight-line signals. The EPR spectra of
the vanadocene species present in the I-blood plasma systems having various resulting pH values are shown
in Figs. 2a,b.
The EPR measurements of I in blood plasma solutions ofvarious resulting pH values ranging from
0.12 to 9.13 have shown the existence of the vanadocene species III, IV, and "vanadocene-citrate". The
species III can be found in the pH range 0.12 7.13 in excellent agreement with results of EPR
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measurements of I in aqueous solutions[16], where this species appears in the pH range 0 7.1. The
complex IV can be identified in 1-blood plasma systems having pH values 3.39 9.13. We find again an
excellent agreement with results obtained for aqueous solutions exhibiting the existence of IV in the pH
range from 3.1 to 11.9. In addition to the EPR signals of the species III and IV we observed an additional
eight-line signal in the I blood plasma system corresponding to a novel vanadocene species, probably a
complex "vanadocene-citrate". The nature of this novel vanadocene species may be elucidated by means of
the EPR spectrum of I in aqueous sodium hydrogen citrate. The eight-line EPR signal of that solution
displays magnetic parameters giso and Ao identical with those of the above "vanadocene-citrate" species. It
should be remembered that the sodium hydrogen citrate is used to stabilize the blood plasma.
I dissolved in the therapeutic solvent system and added to the blood plasma solution affords the
composite EPR spectrum consisting of two eight-line signals corresponding to the species IV and
"vanadocene-citrate".
For next investigation of interactions of I in body fluids we tried to avoid the use of the sodium
hydrogen citrate as stabilizer which is not present in the human body in such a high concentration as used
for blood plasma stabilization. That was why the whole blood was stabilized using EDTA, which does not
react with any relevant vanadocene species. EDTA only reacts with the vanadyl species VII. I dissolved in
the stabilized whole blood shows the single eight-line EPR signal corresponding to the complex
IV. I dissolved in the therapeutic solvent system and subsequently added to the stabilized whole blood
exhibits the same EPR spectrum demonstrating the presence of the complex IV alone.
CONCLUSIONS
Metallocene dichlorides, (rls-CsH)2MC12, (M Ti, V, Nb, Mo), represent a novel class of very
active antitumor agents. In order to reveal the nature of their molecular action it is necessary to know which
particular species enters the tumor cell and interacts with target organelles, biostructures and biomolecules.
Metallocene dichlorides are not stable in aqueous media. They undergo equilibrium aquation, dissociation
and hydrolysis reactions. The knowledge of their behaviour in aqueous media is of fundamental importance
since they meet with the water both at injection application in physiological media and after entering into
biological systems including the tumor cell.
Compound I behaves in most of the physiological solutions, i.e. in solutions the composition and
actual pH value of which mimic those of the blood serum or other body fluids, analogously to its behaviour
in aqueous solutions of corresponding pH value. The hydrolysis products of the I do not therefore react with
any inorganic or organic component of the used physiological solutions in the first coordination sphere of
the central vanadium atom. The stability of the vanadocene ring-V-ring framework in non-deoxygenated,
simple aqueous ones (c.f. ref. 16). This stability difference is most remarkable at physiological pH (~7). when
compound I is dissolved in a Krebs-Ringer physiological solution (pH=7.2), one EPR signal characteristic
of the species IV is observed. This signal shows no decrease of intensity indicating a reaction with air
oxygen even after 24h.
In the therapeutic solvent system under conditions corresponding to in vivo and in vitro biological
experiments and preclinical tests, but with exclusion of air access, I behaves analogously to I in saline
(0.103M NaC1). This means that DMSO does not produce any other vanadocene species than that expected
in saline itself. Therefore, we can conclude the role ofDMSO to lie only in improving the solubility of the
introduced I.
In order to determine which vanadocene species may exist if I (or I dissolved in the therapeutic
solvent system) is introduced into the blood plasma or the whole blood. It was possible to use the knowledge
of the behaviour of I in aqueous and physiological solutions, since the plasma and blood can be regarded as
essentially aqueous solutions despite their system complexity. We can draw one very important conclusion:
compound I does not react with any blood plasma blood components in the first coordination sphere of the
vanadium centre except for the water. Its behaviour in these biological systems corresponds to the reactions
already described in the case of aqueous solutions of the corresponding pH value. This means that the single
vanadocene species IV is present after applying I into whole blood as was anticipated by Toney and
Marks[15]. The species IV does not react with any blood plasma blood component through any reaction
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(e.g. substitution reaction) which would take place in the first (inner) coordination sphere of the central
vanadium atom. The possibility of some reactions of IV which would take place in the second (outer)
coordination sphere is not excluded. However the identification of such a second (outer) sphere interaction
by means of magnetic parameters giso and Aso is probably impossible, since it is the first (inner)
coordination sphere ofa given vanadocene or vanadium d species which determines its gio and Ao values.
The effect of changes in the second sphere on these values is very small and probably hardly perceptible.
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